Literature DB >> 14590643

The Tower of London(DX): a standardized approach to assessing executive functioning in children.

W C Culbertson1, E A Zillmer.   

Abstract

In the current study, the Tower of London (Shallice, 1982) was modified to enhance its clinical utility as a measure of childhood executive functioning. The Tower of London-Drexel (TOL(DX)) was administered to normal control (NC; N = 56) and attention-deficit hyperactivity disorder (ADHD; N = 99) children (ages 7 to 12) to determine whether age-related changes in performance were evident, to gather normative data, and to evaluate the test-retest reliability and criterion-validity of the measure. The results revealed age-related changes in score performance, age-group normative data, an acceptable level of reliability and significant differences in performance of NC and ADHD subjects. Further, discriminant analysis classification rates determined that the TOL(DX) was sensitive and highly specific to ADHD. Implications and limitations of the study are discussed.

Entities:  

Year:  1998        PMID: 14590643

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  20 in total

1.  Which executive functioning deficits are associated with AD/HD, ODD/CD and comorbid AD/HD+ODD/CD?

Authors:  Jaap Oosterlaan; Anouk Scheres; Joseph A Sergeant
Journal:  J Abnorm Child Psychol       Date:  2005-02

2.  Neurocognitive functioning in AD/HD, predominantly inattentive and combined subtypes.

Authors:  Mary V Solanto; Sharone N Gilbert; Anu Raj; John Zhu; Sabrina Pope-Boyd; Sa'brina Pope-Boyd; Brenda Stepak; Lucia Vail; Jeffrey H Newcorn
Journal:  J Abnorm Child Psychol       Date:  2007-07-14

3.  Brief report: Further evidence for inner speech deficits in autism spectrum disorders.

Authors:  Gregory L Wallace; Jennifer A Silvers; Alex Martin; Lauren E Kenworthy
Journal:  J Autism Dev Disord       Date:  2009-06-30

4.  Long-term classroom functioning and its association with neuropsychological and academic performance following traumatic brain injury during early childhood.

Authors:  Amery Treble-Barna; Hanna Schultz; Nori Minich; H Gerry Taylor; Keith Owen Yeates; Terry Stancin; Shari L Wade
Journal:  Neuropsychology       Date:  2017-07       Impact factor: 3.295

5.  HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau.

Authors:  Albert M Anderson; David Croteau; Ronald J Ellis; Debra Rosario; Michael Potter; Gilles J Guillemin; Bruce J Brew; Steven Paul Woods; Scott L Letendre
Journal:  J Neuroimmunol       Date:  2018-03-18       Impact factor: 3.478

6.  Long-Term Neuropsychological Profiles and Their Role as Mediators of Adaptive Functioning after Traumatic Brain Injury in Early Childhood.

Authors:  Amery Treble-Barna; Huaiyu Zang; Nanhua Zhang; H Gerry Taylor; Keith Owen Yeates; Shari Wade
Journal:  J Neurotrauma       Date:  2016-05-09       Impact factor: 5.269

7.  Home Environment as a Predictor of Long-Term Executive Functioning following Early Childhood Traumatic Brain Injury.

Authors:  Christianne Laliberté Durish; Keith Owen Yeates; Terry Stancin; H Gerry Taylor; Nicolay C Walz; Shari L Wade
Journal:  J Int Neuropsychol Soc       Date:  2017-07-20       Impact factor: 2.892

8.  Short-term memory, working memory, and executive functioning in preschoolers: longitudinal predictors of mathematical achievement at age 7 years.

Authors:  Rebecca Bull; Kimberly Andrews Espy; Sandra A Wiebe
Journal:  Dev Neuropsychol       Date:  2008       Impact factor: 2.253

9.  Neurocognitive performance in unmedicated patients with hoarding disorder.

Authors:  Jennifer M Sumner; Carolyn G Noack; J Vincent Filoteo; W Todd Maddox; Sanjaya Saxena
Journal:  Neuropsychology       Date:  2016-02       Impact factor: 3.295

10.  Childhood Executive Functioning Predicts Young Adult Outcomes in 22q11.2 Deletion Syndrome.

Authors:  Avery B Albert; Tamara Abu-Ramadan; Wendy R Kates; Wanda Fremont; Kevin M Antshel
Journal:  J Int Neuropsychol Soc       Date:  2018-10       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.